Global Clinical Diagnostics Automation Market - KPLC 7 News, Lake Charles, Louisiana

Global Clinical Diagnostics Automation Market

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, July 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Clinical Diagnostics Automation Market

 

http://www.reportlinker.com/p0552746/Global-Clinical-Diagnostics-Automation-Market.html

 

This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Thousands by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -

 

Abaxis, Inc.

Abbott Diagnostics, Inc.

Beckman Coulter, Inc.

Becton, Dickinson and Company

bioMérieux SA

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Market Segmentation I-3

Automated Analyzers I-3

Stand-Alone Automation I-4

Total Laboratory Automation I-4

 

 

II. EXECUTIVE SUMMARY

 

1. INDUSTRY OVERVIEW II-1

Changing Attitude towards Automation in Clinical Diagnostic

Laboratories II-1

Primary Factors Encouraging Laboratories to Embrace

Automation - In A Nutshell II-2

Automation - A Panacea to the Laboratories' Plight II-3

The Road Ahead for Clinical Diagnostics Automation II-4

Drivers, Trends and Challenges in the Global Lab Automation

Market - At a Glance II-5

Growth Drivers II-5

Trends II-5

Issues and Challenges II-6

Despite Challenges, Emerging Markets Provide Growth

Opportunities II-6

Developed Nations: Cost Pressures Necessitate New Strategies II-7

Regulatory Environment II-8

Competition II-8

Table 1: Leading Players in the Global Laboratory Automation

Market (2011): Percentage Breakdown of Value Sales for

Danaher, Eppendorf, Perkin Elmer, Tecan, Thermo and Others

(includes corresponding Graph/Chart) II-8

 

2. MARKET TRENDS, DRIVERS AND ISSUES II-9

Need for High-Quality Healthcare Drives Demand for Clinical

Diagnostics Automation II-9

Rising Investments in Biotechnology - A Key Growth Driver II-9

Clinical Diagnostics Automation - A Vital Tool in Patient

Treatment Management II-10

Need to Reduce Turnaround Times - A Major Growth Factor II-10

Increasing Healthcare Spending in Emerging Markets -

Opportunity for growth II-11

Table 2: Healthcare Spending as % of GDP in Select Countries

(2011) (includes corresponding Graph/Chart) II-11

Healthcare Needs of Aging Population - An Important

Opportunity Indicator II-11

Table 3: Elderly Population (60+ Years) as a Percentage of

Total Population (2012 & 2050) (includes corresponding

Graph/Chart) II-12

 

Table 4: Global Aging Population (60+) and their Proportion

of Total Population (2012 & 2050) (includes corresponding

Graph/Chart) II-13

Rapid Detection of Infectious Diseases: Enhancing Need for

Clinical Laboratory Automation Equipment II-14

Table 5: Reported Cases of Major Infectious by Geographic

Region (2011) II-14

Rising Incidence of Cancer to Propels Demand for Clinical

Diagnostics Automation II-14

Table 6: World Cancer Incidence by Geographic Region and

Gender (2012): Number of New Cancer Cases Reported in

Thousands for Asia-Oceania, Europe, North America, Latin

America & the Caribbean, and Africa (includes corresponding

Graph/Chart) II-15

 

Table 7: New Cancer Cases in the World by Affected Site: 2012

(in Thousands) (includes corresponding Graph/Chart) II-16

 

Table 8: World Cancer Mortality by Geographic Region and

Gender (2012): Number of Cancer-Related Deaths in Thousands

for Asia-Oceania, Europe, North America, Latin America & the

Caribbean, and Africa (includes corresponding Graph/Chart) II-17

 

Table 9: Global Incidence of Common Cancers in Men (2012):

Number of New Cases Reported in Thousands for Lung &

Bronchus, Prostate, Colorectal and Liver Cancers (includes

corresponding Graph/Chart) II-17

 

Table 10: Global Incidence of Common Cancers in Women (2012):

Number of New Cases Reported in Thousands for Breast,

Colorectal, Lung & Bronchus and Liver Cancers (includes

corresponding Graph/Chart) II-18

 

Table 11: Global Cancer Mortality in Men for Select Cancers

(2012): Number of Deaths in Thousands for Lung & Bronchus,

Liver, Colorectal and Prostate Cancers (includes

corresponding Graph/Chart) II-18

 

Table 12: Global Cancer Mortality in Women for Select Cancers

(2012): Number of Deaths in Thousands for Breast, Lung &

Bronchus, Colorectal and Liver Cancer Prone Sites based on

Age (includes corresponding Graph/Chart) II-18

Cancer Prone Sites based on Age II-19

End-User and Technology-Led Aspects Drive Demand for Automation II-19

Automation - The Prime Solution to Enhance Laboratory Efficiency II-19

Total Laboratory Automation - Only Good Enough for Large

Hospitals II-19

Large Hospitals See Good Return on Investments by TLA II-20

Issues Continue to Plague Large Scale Automation Solutions II-20

Bright Prospects Ahead for TLA II-20

Modular Automation Surges Ahead of TLA in Adoption II-21

Rising Demand for Automated Hematology Analyzers II-22

Technological Advancements and Rising Awareness Levels Drive

Growth in the Global Biochemistry Analyzers Market II-22

Demand for POC Testing Rises II-23

Automation Liberates Patients from Risk of Pre-analytical

Diagnostic Errors II-23

Blood Gas Analyzers - A Potential Solution to Reduce Time Lag

Between Testing and Results II-24

Point-of-care Testing - A Revolution in the Blood Gas and

Electrolyte Analyzers Market II-24

Automated Multiplexing Technology: Major Role in Clinical

Diagnostics Automation II-25

Multiplex Testing for Herpes Simplex Virus Type 1 and 2 II-26

Microbiology Labs: Growing Need for Automation II-26

Automation to Provide Impetus to New Businesses II-27

Internet Revolutionizes Laboratory Diagnostics II-27

System Compatibility: A Key Requirement II-28

Labor Shortage: A Key Challenge in the Clinical Lab Automation

Market II-28

Clinical Diagnostics Automation to Insulate Effects of

Tightening Labor Market II-28

Bar Code Technology Continues to Gain Adoption in Clinical

Settings II-29

Barcoding Eases Specimen and Consumable Identification II-29

Bar Code Labeling Protects Patient Safety II-30

Benefits of Barcoding to Medical Device Manufacturers II-30

Laboratory Information System - A Key Aspect of Clinical

Diagnostics Automation II-31

Operational Concerns Associated with LIS II-31

 

3. CLINICAL DIAGNOSTICS AUTOMATION - AN OVERVIEW II-32

Laboratory Automation: Order of the Day II-32

Benefits of Laboratory Automation II-32

Introduction to Clinical Diagnostics Automation II-32

Evolution of Clinical Diagnostics Automation II-33

Components of Laboratory Automation System II-33

Typical Diagnostic Laboratory Structure II-33

Laboratory Control and Information System II-34

Sample Storage II-34

Sample Preparation II-34

Transportation II-34

Analysis II-34

Clinical Diagnostics Automation by Market Segment II-35

Automated Analyzers II-35

Stand-Alone Automation II-35

Total Laboratory Automation (TLA) II-35

Limitations of TLA Systems II-36

Modular Automation: Emerging Alternative II-36

Total Laboratory Automation (TLA) Vs. Modular Laboratory

Automation II-36

Decentralized Testing Gains Importance II-36

Advantages of POC Testing Over Centralized Laboratory Testing II-37

Cost Analysis of POC Testing Vs. Laboratory Testing II-37

Cost Savings through Space Savings II-38

Major Components of Multi-Step Automation Process II-38

Consolidation of Workstation II-38

Information Management II-38

 

4. PRODUCT INTRODUCTIONS/INNOVATIONS II-39

Hamilton Unveils LabElite Range of Automated Benchtop Devices II-39

Axiom Veterinary Laboratories Rolled out MiLab Range II-39

Transasia Unveils Five New Automated Lab Instruments II-39

Transasia Bio-Medicals Unveils Sysmex XN Series Differential

Haematology Analyser II-39

Immunetics Launches BacTx Analyzer for Use with BacTx Rapid Test II-39

SIEMENS Launches VersaCell X3 Solution II-39

Roche Launches cobas 8100 Automated Workflow Series II-39

Roche Launches cobas® 6800 and cobas® 8800 Systems II-40

Abbott Launches ACCELERATOR® a3600 Next Generation Automation

Solution II-40

Beckman Coulter Launches UniCel DxH 600 Benchtop Hematology

Analyzer II-40

Microscan Unveiled Auto ID and Machine Vision Technologies Line II-40

Siemens Unveils Sysmex® CS-5100 System II-40

Siemens Launches Aptio™ Automation II-40

Roche Launches cobas p 312 Pre-Analytical System II-40

Randox Unveils RX Daytona Compact Clinical Chemistry Analyser II-40

 

5. RECENT INDUSTRY ACTIVITY II-41

Carlyle Group to Acquire Ortho-Clinical Diagnostics II-41

Singulex Partners with Tecan for Commercial Development of

Ultrasensitive Sgx Clarity™ System II-41

Roche and Hitachi Renew Development and Manufacturing Contract II-41

Sysmex America Inks Distribution Agreement with Henry Schein II-41

ERBA Diagnostics Receives FDA Approval for XL200 Clinical

Chemistry Analyzer II-41

Abaxis Receives Health Canada Class III Clearance for Piccolo

Xpress® II-41

NorDx to Acquire Sysmex® XN-Series Automated Hematology Analyzers II-42

Francisco Partners Takes over McKesson's Hospital Automation Unit II-42

Cerner Takes over Labotix Automation II-42

Bio-Rad Enters into Development Agreement with Inpeco II-42

CryoXtract™ Inks Distribution Agreement with Bio-Strategy Ltd II-42

CML HealthCare Enters into Vendor Supply Agreement with Sysmex

Canada II-42

BD Completes Takeover of KIESTRA Lab Automation BV II-42

Sysmex America Receives FDA Clearance of XN-Series Hematology

Analyzers Products II-43

IRIS International Inked Distribution Agreement with Alifax II-43

 

6. FOCUS ON SELECT GLOBAL PLAYERS II-44

Abaxis, Inc. (US) II-44

Abbott Diagnostics, Inc. (US) II-44

Beckman Coulter, Inc. (US) II-45

Becton, Dickinson and Company (US) II-45

bioMérieux SA (France) II-46

Bio-Rad Laboratories, Inc. (US) II-46

Diagnostica Stago (France) II-47

Eppendorf AG (Germany) II-47

F. Hoffmann-La Roche Ltd. (Switzerland) II-47

HORIBA ABX S.A.S. (France) II-47

Hudson Robotics, Inc. (US) II-48

Ortho Clinical Diagnostics, Inc. (US) II-48

PerkinElmer Inc. (US) II-48

QIAGEN NV (The Netherlands) II-49

Siemens Healthcare Diagnostics, Inc. (US) II-49

Sysmex America, Inc. (US) II-49

Tecan Group Ltd. (Switzerland) II-50

The ELITechGroup SAS (France) II-50

Thermo Fisher Scientific, Inc. (US) II-51

 

7. GLOBAL MARKET PERSPECTIVE II-52

Table 13: World Recent Past, Current and Future Analysis for

Clinical Diagnostics Automation by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America, and Rest of World Markets Independently Analyzed with

Annual Revenue Figures in US$ Thousand for Years 2013 through

2020 (includes corresponding Graph/Chart) II-52

 

Table 14: World Historic Review for Clinical Diagnostics

Automation by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Revenue

Figures in US$ Thousand for Years 2006 through 2012 (includes

corresponding Graph/Chart) II-53

 

Table 15: World 15-Year Perspective for Clinical Diagnostics

Automation by Geographic Region - Percentage Breakdown of

Revenues for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

for Years 2006, 2014 & 2020 (includes corresponding

Graph/Chart) II-54

 

Table 16: World Recent Past, Current and Future Analysis for

Automated Analyzers by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America, and

Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) II-55

 

Table 17: World Historic Review for Automated Analyzers by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-56

 

Table 18: World 15-Year Perspective for Automated Analyzers by

Geographic Region - Percentage Breakdown of Revenues for US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America, and Rest of World Markets for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) II-57

 

Table 19: World Recent Past, Current and Future Analysis for

Total Lab Automation by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America, and

Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) II-58

 

Table 20: World Historic Review for Total Lab Automation by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-59

 

Table 21: World 15-Year Perspective for Total Lab Automation

by Geographic Region - Percentage Breakdown of Revenues for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America, and Rest of World Markets for Years 2006, 2014 &

2020 (includes corresponding Graph/Chart) II-60

 

Table 22: World Recent Past, Current and Future Analysis for

Stand-alone Automation by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America,

and Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) II-61

 

Table 23: World Historic Review for Stand-alone Automation by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-62

 

Table 24: World 15-Year Perspective for Stand-alone Automation

by Geographic Region - Percentage Breakdown of Revenues for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America, and Rest of World Markets for Years 2006, 2014 &

2020 (includes corresponding Graph/Chart) II-63

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current and Future Analysis III-1

Healthcare Industry Dynamics Augur Well for Lab Automation III-1

Table 25: Healthcare Spending as a % of GDP (includes

corresponding Graph/Chart) III-2

Growing Complexity of Tests Necessitates Automation of Lab

Operations III-3

Increasing Pressure on Healthcare Organizations Fuels

Adoption of Laboratory Automation Systems III-3

Shortage of Qualified Lab Workforce: A Major Growth Driver III-4

Table 26: Overall Vacancy Rates (%) by Laboratory

Departments for the Year 2012 (includes corresponding

Graph/Chart) III-5

Rising Diagnostic Needs of Aging Population III-5

Table 27: North American Elderly Population by Age Group

(1975-2050) (includes corresponding Graph/Chart) III-6

Table 28: US Population Breakdown by Age Group (2012) (

includes corresponding Graph/Chart) III-7

TLA Systems: Improving Quality & Turnaround Times III-7

Modular Automation Scores over Total Laboratory Automation

Approach III-7

Automation Ensures Error-Free and Faster Test Results III-8

Regulations Dictate Technological Changes in Laboratories III-8

FDA Regulations and Classification of Devices in Clinical

Laboratory Automation III-8

Product launches III-9

Strategic corporate developments III-11

Key Players III-13

B.Market Analytics III-18

Table 29: US Recent Past, Current and Future Analysis for

Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-18

 

Table 30: US Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-19

 

Table 31: US 15-Year Perspective for Clinical Diagnostics

Automation by Segment - Percentage Breakdown of Revenues for

Automated Analyzers, Total Lab Automation and Stand-alone

Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-20

 

2. CANADA III-21

A.Market Analysis III-21

Outlook III-21

Strategic Corporate Development III-21

B.Market Analytics III-22

Table 32: Canadian Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-22

 

Table 33: Canadian Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-23

 

Table 34: Canadian 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-24

 

3. JAPAN III-25

Market Analysis III-25

Table 35: Japanese Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-26

 

Table 36: Japanese Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-27

 

Table 37: Japanese 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-28

 

4. EUROPE III-29

A.Market Analysis III-29

European Clinical Diagnostics Automation Market: A Prelude III-29

Clinical Diagnostics Market: An Overview III-30

Table 38: Diagnostics Market in Europe (2012): Percentage

Share Breakdown of Revenues by Medical Imaging, Laboratory

Testing, and Anatomic Pathology (includes corresponding

Graph/Chart) III-30

Debt Crisis in Europe Affects Healthcare Industry III-31

Increasing Testing Needs of the Elderly: Business Case for

Lab Automation III-31

Table 39: Population Breakup by Age Group for Select

European Countries: 2012 (As a % of Total Population)

(includes corresponding Graph/Chart) III-32

Manufacturers Face Significant Challenges III-33

Automation Supports Growth in West European IVD Market III-33

B.Market Analytics III-34

Table 40: European Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Geographic Region -

France, Germany, Italy, UK, Spain, Russia and Rest of Europe

Markets Independently Analyzed with Annual Revenue Figures

in US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-34

 

Table 41: European Historic Review for Clinical Diagnostics

Automation by Geographic Region - France, Germany, Italy,

UK, Spain, Russia and Rest of Europe Markets Independently

Analyzed with Annual Revenue Figures in US$ Thousand for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-35

 

Table 42: European 15-Year Perspective for Clinical

Diagnostics Automation by Geographic Region - Percentage

Breakdown of Revenues for France, Germany, Italy, UK, Spain,

Russia and Rest of Europe Markets for Years 2006, 2014 &

2020 (includes corresponding Graph/Chart) III-36

 

Table 43: European Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-37

 

Table 44: European Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-38

 

Table 45: European 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-39

 

4a. FRANCE III-40

A.Market Analysis III-40

Key Players III-40

B.Market Analytics III-42

Table 46: French Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-42

 

Table 47: French Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-43

 

Table 48: French 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-44

 

4b. GERMANY III-45

A.Market Analysis III-45

Product Launch III-45

B.Market Analytics III-46

Table 49: German Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-46

 

Table 50: German Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-47

 

Table 51: German 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-48

 

4c. ITALY III-49

Market Analysis III-49

Table 52: Italian Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-49

 

Table 53: Italian Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-50

 

Table 54: Italian 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-51

 

4d. THE UNITED KINGDOM III-52

A.Market Analysis III-52

Product launch III-52

B.Market Analytics III-53

Table 55: UK Recent Past, Current and Future Analysis for

Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-53

 

Table 56: UK Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-54

 

Table 57: UK 15-Year Perspective for Clinical Diagnostics

Automation by Segment - Percentage Breakdown of Revenues for

Automated Analyzers, Total Lab Automation and Stand-alone

Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-55

 

4e. SPAIN III-56

Market Analysis III-56

Table 58: Spanish Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-56

 

Table 59: Spanish Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-57

 

Table 60: Spanish 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-58

 

4f. RUSSIA III-59

Market Analysis III-59

Table 61: Russian Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-59

 

Table 62: Russian Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-60

 

Table 63: Russian 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-61

 

4g. REST OF EUROPE III-62

A.Market Analysis III-62

Product Launches III-62

Strategic corporate development III-62

Key Players III-62

B.Market Analytics III-64

Table 64: Rest of Europe Recent Past, Current and Future

Analysis for Clinical Diagnostics Automation by Segment -

Automated Analyzers, Total Lab Automation and Stand-alone

Automation Independently Analyzed with Annual Revenue

Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) III-64

 

Table 65: Rest of Europe Historic Review for Clinical

Diagnostics Automation by Segment - Automated Analyzers,

Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) III-65

 

Table 66: Rest of Europe 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-66

 

5. ASIA-PACIFIC III-67

A.Market Analysis III-67

Outlook III-67

Healthcare Spending in Asia-Pacific: On the Rise III-67

B.Market Analytics III-68

Table 67: Asia-Pacific Recent Past, Current and Future

Analysis for Clinical Diagnostics Automation by Geographic

Region - China, India and Rest of Asia-Pacific Markets

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-68

 

Table 68: Asia-Pacific Historic Review for Clinical

Diagnostics Automation by Geographic Region - China, India

and Rest of Asia-Pacific Markets Independently Analyzed with

Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-69

 

Table 69: Asia-Pacific 15-Year Perspective for Clinical

Diagnostics Automation by Geographic Region - Percentage

Breakdown of Revenues for China, India and Rest of

Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-70

 

Table 70: Asia-Pacific Recent Past, Current and Future

Analysis for Clinical Diagnostics Automation by Segment -

Automated Analyzers, Total Lab Automation and Stand-alone

Automation Independently Analyzed with Annual Revenue

Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) III-71

 

Table 71: Asia-Pacific Historic Review for Clinical

Diagnostics Automation by Segment - Automated Analyzers,

Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) III-72

 

Table 72: Asia-Pacific 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-73

 

5a. CHINA III-74

A.Market Analysis III-74

Outlook III-74

Healthcare Reforms: Opportunities for Clinical Labs Market III-74

B.Market Analytics III-75

Table 73: Chinese Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-75

 

Table 74: Chinese Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-76

 

Table 75: Chinese 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-77

 

5b. INDIA III-78

A.Market Analysis III-78

Automation of Clinical Laboratories on the Rise III-78

Challenges Abound in the Indian Clinical Diagnostics Labs

Market III-78

Private Enterprises Encourage Changes in Diagnostics Sector III-79

Indian Blood Gas and Electrolyte Analyzers Market III-79

Table 76: Indian Blood Gas and Electrolyte Analyzers and

Reagents (2013): Percentage Breakdown of Value and Volume

Sales by Segment (includes corresponding Graph/Chart) III-79

A List of Key Vendors in the Indian Blood Gas and

Electrolyte Analyzers and Reagents Market III-80

Product launches III-80

B.Market Analytics III-81

Table 77: Indian Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-81

 

Table 78: Indian Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-82

 

Table 79: Indian 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-83

 

5c. REST OF ASIA-PACIFIC III-84

A.Market Analysis III-84

Outlook III-84

Singapore III-84

B.Market Analytics III-85

Table 80: Rest of Asia-Pacific Recent Past, Current and

Future Analysis for Clinical Diagnostics Automation by

Segment - Automated Analyzers, Total Lab Automation and

Stand-alone Automation Independently Analyzed with Annual

Revenue Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) III-85

 

Table 81: Rest of Asia-Pacific Historic Review for Clinical

Diagnostics Automation by Segment - Automated Analyzers,

Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) III-86

 

Table 82: Rest of Asia-Pacific 15-Year Perspective for

Clinical Diagnostics Automation by Segment - Percentage

Breakdown of Revenues for Automated Analyzers, Total Lab

Automation and Stand-alone Automation for Years 2006, 2014 &

2020 (includes corresponding Graph/Chart) III-87

 

6. LATIN AMERICA III-88

Market Analysis III-88

Table 83: Latin American Recent Past, Current and Future

Analysis for Clinical Diagnostics Automation by Geographic

Region - Brazil and Rest of Latin America Markets

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-88

 

Table 84: Latin American Historic Review for Clinical

Diagnostics Automation by Geographic Region - Brazil and

Rest of Latin America Markets Independently Analyzed with

Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-89

 

Table 85: Latin American 15-Year Perspective for Clinical

Diagnostics Automation by Geographic Region - Percentage

Breakdown of Revenues for Brazil and Rest of Latin America

Markets for Years 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-90

 

Table 86: Latin American Recent Past, Current and Future

Analysis for Clinical Diagnostics Automation by Segment -

Automated Analyzers, Total Lab Automation and Stand-alone

Automation Independently Analyzed with Annual Revenue

Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) III-91

 

Table 87: Latin American Historic Review for Clinical

Diagnostics Automation by Segment - Automated Analyzers,

Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) III-92

 

Table 88: Latin American 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-93

 

6a. BRAZIL III-94

A.Market Analysis III-94

Outlook III-94

Clinical Diagnostics Automation Market Poised to Grow III-94

Table 89: Brazilian Clinical Diagnostics Automation Market

(2011): Market Share Breakdown by Leading Companies -

Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare,

and Others (includes corresponding Graph/Chart) III-94

B.Market Analytics III-95

Table 90: Brazilian Recent Past, Current and Future Analysis

for Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-95

 

Table 91: Brazilian Historic Review for Clinical Diagnostics

Automation by Segment - Automated Analyzers, Total Lab

Automation and Stand-alone Automation Independently Analyzed

with Annual Revenue Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) III-96

 

Table 92: Brazilian 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-97

 

6b. REST OF LATIN AMERICA III-98

Market Analysis III-98

Table 93: Rest of Latin American Recent Past, Current and

Future Analysis for Clinical Diagnostics Automation by

Segment - Automated Analyzers, Total Lab Automation and

Stand-alone Automation Independently Analyzed with Annual

Revenue Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) III-98

 

Table 94: Rest of Latin American Historic Review for

Clinical Diagnostics Automation by Segment - Automated

Analyzers, Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Revenue Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) III-99

 

Table 95: Rest of Latin American 15-Year Perspective for

Clinical Diagnostics Automation by Segment - Percentage

Breakdown of Revenues for Automated Analyzers, Total Lab

Automation and Stand-alone Automation for Years 2006, 2014 &

2020 (includes corresponding Graph/Chart) III-100

 

7. REST OF WORLD III-101

A.Market Analysis III-101

Outlook III-101

South Africa III-101

Major Challenges Impeding Laboratory Automation in Africa III-101

B.Market Analytics III-103

Table 96: Rest of World Recent Past, Current and Future

Analysis for Clinical Diagnostics Automation by Segment -

Automated Analyzers, Total Lab Automation and Stand-alone

Automation Independently Analyzed with Annual Revenue

Figures in US$ Thousand for Years 2013 through 2020

(includes corresponding Graph/Chart) III-103

 

Table 97: Rest of World Historic Review for Clinical

Diagnostics Automation by Segment - Automated Analyzers,

Total Lab Automation and Stand-alone Automation

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) III-104

 

Table 98: Rest of World 15-Year Perspective for Clinical

Diagnostics Automation by Segment - Percentage Breakdown of

Revenues for Automated Analyzers, Total Lab Automation and

Stand-alone Automation for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-105

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 57 (including Divisions/Subsidiaries - 62)

 

The United States (37)

Canada (2)

Japan (1)

Europe (19)

- France (3)

- Germany (3)

- The United Kingdom (6)

- Italy (1)

- Rest of Europe (6)

Asia-Pacific (Excluding Japan) (3)

 

 

 

To order this report: Global Clinical Diagnostics Automation Market

http://www.reportlinker.com/p0552746/Global-Clinical-Diagnostics-Automation-Market.html

__________________________

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow